ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 64 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $0 | -100.0% | 3 | -100.0% | 0.00% | – |
| Q2 2018 | $51,000 | -10.5% | 38,311 | -4.0% | 0.00% | – |
| Q1 2018 | $57,000 | -61.5% | 39,900 | -39.7% | 0.00% | – |
| Q4 2017 | $148,000 | +39.6% | 66,180 | +110.5% | 0.00% | – |
| Q3 2017 | $106,000 | -14.5% | 31,441 | -11.2% | 0.00% | – |
| Q2 2017 | $124,000 | +396.0% | 35,414 | +361.3% | 0.00% | – |
| Q1 2017 | $25,000 | -69.9% | 7,677 | -58.2% | 0.00% | – |
| Q4 2016 | $83,000 | +50.9% | 18,357 | +37.7% | 0.00% | – |
| Q3 2016 | $55,000 | +77.4% | 13,335 | +2.0% | 0.00% | – |
| Q2 2016 | $31,000 | -40.4% | 13,070 | +17.4% | 0.00% | – |
| Q1 2016 | $52,000 | +13.0% | 11,133 | -8.6% | 0.00% | – |
| Q4 2015 | $46,000 | -4.2% | 12,177 | -2.4% | 0.00% | – |
| Q3 2015 | $48,000 | +336.4% | 12,475 | +396.8% | 0.00% | – |
| Q2 2015 | $11,000 | – | 2,511 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 5,292,156 | $7,674,000 | 1.12% |
| Northeast Financial Consultants Inc | 732,265 | $1,061,000 | 0.36% |
| Family Management Corp | 10,424 | $15,000 | 0.01% |
| AJ WEALTH STRATEGIES, LLC | 15,000 | $22,000 | 0.01% |
| Poehling Capital Management, INC. | 3,302 | $5,000 | 0.00% |
| A.R.T. Advisors, LLC | 48,692 | $70,000 | 0.00% |
| Virtu Financial LLC | 34,383 | $50,000 | 0.00% |
| Founders Capital Management | 3,000 | $4,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 151,854 | $220,000 | 0.00% |
| BEACON INVESTMENT ADVISORY SERVICES, INC. | 10,500 | $15,000 | 0.00% |